• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Immunodominant SARS-CoV-2-specific CD4+ and CD8+ T-cell responses elicited by inactivated vaccines in healthy adults

tetano

Editor, Senior Moderator
J Med Virol


. 2023 Apr;95(4):e28743.
doi: 10.1002/jmv.28743. Immunodominant SARS-CoV-2-specific CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T-cell responses elicited by inactivated vaccines in healthy adults

Jie Ning[SUP] 1 [/SUP], Qinjin Wang[SUP] 1 [/SUP], Ying Chen[SUP] 1 [/SUP], Taojun He[SUP] 1 [/SUP], Fang Zhang[SUP] 1 [/SUP], Xingchi Chen[SUP] 1 [/SUP], Liang Shi[SUP] 1 [/SUP], Aixia Zhai[SUP] 1 [/SUP], Bin Li[SUP] 1 [/SUP], Chao Wu[SUP] 1 [/SUP]



Affiliations
Abstract

Safety profiles and humoral responses to inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been previously assessed, but cellular immune responses to inactivated SARS-CoV-2 vaccines remain understudied. Here, we report the comprehensive characteristics of SARS-CoV-2-specific CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T-cell responses elicited by the BBIBP-CorV vaccine. A total of 295 healthy adults were recruited, and SARS-CoV-2-specific T-cell responses were detected after stimulation with overlapping peptide pools spanning the entire length of the envelope (E), membrane (M), nucleocapsid (N), and spike (S) proteins. Robust and durable CD4[SUP]+[/SUP] (p < 0.0001) and CD8[SUP]+[/SUP] (p < 0.0001) T-cell responses specific to SARS-CoV-2 were detected following the third vaccination, with an increase in specific CD8[SUP]+[/SUP] T-cells, compared to CD4[SUP]+[/SUP] T-cells. Cytokine profiles showed that interferon gamma and tumor necrosis factor-α were predominantly expressed with the negligible expression of interleukin (IL)-4 and IL-10, indicating a Th1- or Tc1-biased response. Compared to E and M proteins, N and S activated a higher proportion of specific T-cells with broader functions. The predominant frequency of the N antigen (49/89) was highest for CD4[SUP]+[/SUP] T-cell immunity. Furthermore, N[SUB]19-36[/SUB] and N[SUB]391-408[/SUB] were identified to contain dominant CD8[SUP]+[/SUP] and CD4[SUP]+[/SUP] T-cell epitopes, respectively. In addition, N[SUB]19-36[/SUB] -specific CD8[SUP]+[/SUP] T-cells were mainly effector memory CD45RA cells, whereas N[SUB]391-408[/SUB] -specific CD4[SUP]+[/SUP] T-cells were mainly effector memory cells. Therefore, this study reports comprehensive features of T-cell immunity induced by the inactivated SARS-CoV-2 vaccine BBIBP-CorV and proposes highly conserved candidate peptides which may be beneficial in vaccine optimization.

Keywords: BBIBP-CorV; SARS-CoV-2; cellular immunity; inactivated vaccine.

 
Back
Top Bottom